ENTA: Unless they can lay out a solid argument/scenario for success, given the other potential (and further along) NASH therapies on the market, then they really need to do what's right for shareholders and drop this effort. The stock immediately recovers 10 points at least.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.